The Feasibility of Patient-Specific Circulating Tumor DNA Monitoring throughout Multi-Modality Therapy for Locally Advanced Esophageal and Rectal Cancer: A Potential Biomarker for Early Detection of Subclinical Disease.

If the observed number of mutant consensus reads exceeded this value, we considered it to be marginally significant and therefore above the limit of detection (see Supplementary Table S4 for p -values and binomial test results for each panel at each time point).

also in 26,082 other papers